Healthcare - Press Releases

Date	Title	Company
11-Mar-2020	Tiziana Life Sciences plc To Expedite Development of its Fully Human Anti-Interleukin-6-Receptor Monoclonal Antibody, a Potential Treatment of Certain Patients Infected with Coronavirus COVID-19	Tiziana Life Sciences plc
11-Mar-2020	BillionToOne has raised more than $32.5 million. The funding will be used to support the commercial expansion of UNITY™ to all US states	BillionToOne
11-Mar-2020	First mental health trust joins collaboration of North East NHS organisations to drive forward digital health technology within the region	Health Call
11-Mar-2020	Drugs alone cannot improve diabetes patients’ outcomes	GlobalData
11-Mar-2020	Overcoming Data Collection and System Challenges in Real World Studies, Upcoming Webinar Presented Byr Cmed	Cmed Clinical Research Services
10-Mar-2020	PharmiWeb Launches New Job Board for Pharma & Life Sciences in Australasia	PharmiWeb
10-Mar-2020	Paradigm Shift in Angiography: Kinepict Medical Imaging Technology (KMIT) Receives US FDA 510(K) Clearance	Kinepict Health Ltd.
10-Mar-2020	Freeline receives Orphan Drug Designation from the European Commission for FLT190 for the treatment of Fabry Disease	Freeline
10-Mar-2020	Orgenesis Year-End Results, outlines business model and POCare strategy post-Masthercell sale	Orgenesis
10-Mar-2020	Pivotal Acquires Akcelis, an Industry Leader in Patient Engagement, Recruitment and Retention	Pivotal
10-Mar-2020	Locust Walk Appointed Strategic and Business Development Advisor for the Licensing Process of ILB™	TIKOMED
10-Mar-2020	Immutep receives second IND approval for Efti from US FDA	Immutep Limited
10-Mar-2020	New initiative to give cancer patients easier access to clinical trials and increase patient diversity in research	The Christie NHS Foundation Trust and Innovative Trials
09-Mar-2020	Chemotherapy after surgery halves risk of rare kidney cancer coming back	The Institute of Cancer Research
09-Mar-2020	Nanoform and Orion collaborate on next-generation drug development	Nanoform
09-Mar-2020	Kancera provides an update on the development of the drug candidate KAND145	Kancera AB
09-Mar-2020	Hansa Biopharma announces long term follow-up data that demonstrates 2-year graft survival of 89% after imlifdase treatment and transplantation	Hansa Biopharma AB
09-Mar-2020	Marinomed extends the range of Marinosolv® applications	Marinomed Biotech AG
09-Mar-2020	SHIONOGI ANNOUNCES LAUNCH OF MULPLEO® (LUSUTROMBOPAG) IN THE UK, FOR THE TREATMENT OF SEVERE THROMBOCYTOPENIA IN ADULT PATIENTS WITH CHRONIC LIVER DISEASE UNDERGOING INVASIVE PROCEDURES	Shionogi & Co., Ltd
06-Mar-2020	Orexo submits application for vorvida® to the FDA to enable commercialization in the US	Orexo AB